Plus: Chicago school board approves controversial $175 million pension payment to the city, AbbVie raises outlook on strong ...

Don Wilson’s trading powerhouse DRW Holdings of Chicago and Liberty City Ventures have entered into a subscription agreement with Tharimmune Inc., a listed vehicle whose primary purpose is to raise ...

Chuy Garcia is just the latest incumbent to leave a Congressional seat. Raja Krishnamoorthi isn’t seeking re-election in the ...

Three employees at cybersecurity companies spent years moonlighting as criminal hackers, launching their own ransomware ...

Federal Reserve Bank of Chicago President Austan Goolsbee said he wants to see more data before making a decision about how ...

Lou Sandoval is out as CEO of the Illinois Chamber of Commerce after two years. The chamber declined to comment further on Sandoval’s departure. Board Chairman Dan Wagner has been named interim CEO of ...

Ten City Council members are demanding Ernst & Young testify about their $3.2 million audit of Mayor Brandon Johnson’s 2026 ...

The expansion includes at least one other new location in Chicago. Crain's reported in October that Trader Joe's is coming to ...

The start of construction of the campus hinges on state environmental officials approving plans to remediate the site and protect area residents.

Michael Fassnacht is former CEO of World Business Chicago and is now chief growth officer at Clayco in Chicago. You'll find his previous "Beyond the Status Quo" columns here.

Menashe Properties bought the 31-story building at 125 S. Wacker Drive for 64% less than the property's 2017 sale price.

Board-certified hematologic oncologists and stem cell transplant experts Jacob D. Bitran, M.D., M.B.A., F.A.C.P., and Neil Dunavin, M.D., M.S., have joined the longstanding hematologic oncology, bone ...